
Aethlon Medical AEMD
$ 3.09
-9.12%
Quarterly report 2025-Q3
added 11-12-2025
Aethlon Medical Gross Profit 2011-2025 | AEMD
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | 1.36 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.36 M | 1.36 M | 1.36 M |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
67.9 M | - | - | $ 1.77 B | ||
|
Abiomed
ABMD
|
690 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
-3.14 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
33.8 M | $ 3.83 | -0.91 % | $ 133 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
584 K | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
342 M | $ 306.74 | -0.45 % | $ 8.65 B | ||
|
Apollo Endosurgery
APEN
|
42.4 M | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
229 K | - | 37.08 % | $ 85.7 M | ||
|
InMode Ltd.
INMD
|
317 M | $ 14.35 | -1.1 % | $ 1.14 B | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 0.99 | 7.52 % | $ 16 M | ||
|
Bruker Corporation
BRKR
|
1.65 B | $ 45.67 | 1.2 % | $ 6.8 K | ||
|
Allied Healthcare Products
AHPI
|
443 K | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
18.7 B | $ 128.62 | 2.52 % | $ 224 B | ||
|
Boston Scientific Corporation
BSX
|
11.5 B | $ 91.86 | -0.78 % | $ 135 B | ||
|
Conformis
CFMS
|
23.2 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
871 M | $ 63.33 | 0.92 % | $ 3.44 B | ||
|
CryoLife, Inc.
CRY
|
168 M | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
26.6 M | $ 3.19 | 10.76 % | $ 119 M | ||
|
LENSAR
LNSR
|
14.1 M | $ 11.5 | -0.09 % | $ 132 M | ||
|
Cardiovascular Systems
CSII
|
173 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-12.7 M | - | -10.19 % | $ 1.99 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
28.7 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
43.7 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
1.99 M | - | - | $ 111 M | ||
|
Eargo
EAR
|
14.3 M | - | - | $ 10.2 M | ||
|
PAVmed
PAVM
|
-85 K | $ 0.31 | -4.88 % | $ 2.24 M | ||
|
Dynatronics Corporation
DYNT
|
6.01 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
50.2 M | - | - | $ 955 M | ||
|
Cognyte Software Ltd.
CGNT
|
247 M | $ 9.6 | -2.64 % | $ 689 M | ||
|
Profound Medical Corp.
PROF
|
4.38 M | $ 7.74 | 5.53 % | $ 180 M | ||
|
Quanterix Corporation
QTRX
|
70.6 M | $ 7.5 | -0.86 % | $ 282 M | ||
|
IRadimed Corporation
IRMD
|
56.3 M | $ 97.18 | 0.99 % | $ 1.23 B | ||
|
Second Sight Medical Products
EYES
|
500 K | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
2.8 B | $ 163.64 | -1.08 % | $ 12.3 B | ||
|
Accuray Incorporated
ARAY
|
147 M | $ 1.05 | -0.94 % | $ 108 M | ||
|
Avinger
AVGR
|
2 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
19.1 M | $ 12.52 | -1.49 % | $ 338 M | ||
|
FONAR Corporation
FONR
|
42.4 M | $ 14.9 | 1.02 % | $ 97.7 M | ||
|
AxoGen
AXGN
|
142 M | $ 29.72 | -2.2 % | $ 1.32 B | ||
|
Axonics Modulation Technologies
AXNX
|
198 M | - | - | $ 3.31 B | ||
|
GBS
GBS
|
1.25 M | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
733 M | $ 40.32 | -1.26 % | $ 1.24 B | ||
|
OrthoPediatrics Corp.
KIDS
|
149 M | $ 17.74 | 0.8 % | $ 409 M | ||
|
Globus Medical
GMED
|
719 M | $ 86.69 | - | $ 11.8 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
953 M | $ 13.55 | 0.97 % | $ 1.04 B | ||
|
Aziyo Biologics
AZYO
|
11.1 M | - | 1.37 % | $ 20.5 M |